Keywords: abbott, labs, reports, double-digit, growth, 2nd, qtr
Abbott Labs reports double-digit growth in 2nd qtr, driven by pharma sales
Article | 22 July 2002
USA-based Abbott Laboratories has reported sales of $4.3 billion for thesecond quarter ended June 30, 2002, an increase of 6.3% (without the impact of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
